Format
Items per page
Sort by

Send to:

Choose Destination

Results: 7

Related Articles by Review for PubMed (Select 23185274)

1.

Gefitinib analogue V1801 induces apoptosis of T790M EGFR-harboring lung cancer cells by up-regulation of the BH-3 only protein Noxa.

Zhang B, Jiao J, Liu Y, Guo LX, Zhou B, Li GQ, Yao ZJ, Zhou GB.

PLoS One. 2012;7(11):e48748. doi: 10.1371/journal.pone.0048748. Epub 2012 Nov 21.

2.

Challenges of detecting EGFR T790M in gefitinib/erlotinib-resistant tumours.

Jänne PA.

Lung Cancer. 2008 Jun;60 Suppl 2:S3-9. doi: 10.1016/S0169-5002(08)70099-0. Review.

PMID:
18513582
3.

Erlotinib or gefitinib for the treatment of relapsed platinum pretreated non-small cell lung cancer and ovarian cancer: a systematic review.

Murphy M, Stordal B.

Drug Resist Updat. 2011 Jun;14(3):177-90. doi: 10.1016/j.drup.2011.02.004. Epub 2011 Mar 24. Review.

PMID:
21435938
4.

[Indication of EGFR kinase inhibitors should be refined].

Heneberg P.

Klin Onkol. 2011;24(2):87-93. Review. Czech.

PMID:
21644362
5.

Epidermal growth factor receptor tyrosine kinase inhibitors: current status and future perspectives in the development of novel irreversible inhibitors for the treatment of mutant non-small cell lung cancer.

Galvani E, Alfieri R, Giovannetti E, Cavazzoni A, La Monica S, Galetti M, Fumarola C, Bonelli M, Mor M, Tiseo M, Peters GJ, Petronini PG, Ardizzoni A.

Curr Pharm Des. 2013;19(5):818-32. Review.

PMID:
22973953
6.

BIBW 2992 in non-small cell lung cancer.

Subramaniam DS, Hwang J.

Expert Opin Investig Drugs. 2011 Mar;20(3):415-22. doi: 10.1517/13543784.2011.557063. Review.

PMID:
21320004
7.

Lung cancer chemotherapy, new treatment and related patents.

Cheepsattayakorn A, Cheepsattayakorn R.

Recent Pat Anticancer Drug Discov. 2014;9(3):372-81. Review.

PMID:
24844233
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk